ISRCTN38736987已完成未知
A randomised, double-blind, placebo-controlled trial assessing the safety and efficacy of intracoronary NITRITE infusion during Acute Myocardial Infarction
Barts and The London NHS Trust (UK)0 个研究点目标入组 80 人开始时间: 2013年1月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
- 2013 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/23550096 2. 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/25512434 (added 27/08/2019) 3. 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/27683405
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients aged at least 18 years, upper age limit 80 years, male and female
- •2. Acute ST-elevation myocardial infarction with ECG showing at least 2 mm of ST segment elevation in 2 or more limb leads or 1mm in 2 or more contiguous chest leads, or new left bundle branch block
- •3. Haemodynamically stable
- •4. Estimated symptom to balloon or aspiration time < 6 hours
- •5. A signed and dated written informed consent prior to admission to the study
- •6. Angiographicallly
- •6.1. Primary Percutaneous Coronary Intervention (PPCI) indicated for revascularisation
- •6.2. Single epicardial artery to be treated
- •6.3. Expected ability to use the over the wire balloon for delivery of nitrite
排除标准
- •1. Patients already on nitrate Treatment (Nicorandil, ISMN)
- •2. Previous history of myocardial infarction (MI) or systolic dysfunction
- •3. Previous coronary artery bypass surgery (CABG)
- •4. Subjects presenting with cardiogenic shock (SBP <80 mmHg for >30 minutes, or requiring inotropes or emergency IntraAortic
- •Balloon Pump (IABP) for hypotension treatment) or cardiopulmonary resuscitation
- •5. Current diagnosis of or treatment for malignancy, other than non-melanoma skin cancer
- •6. Current life-threatening condition other than vascular disease that may prevent a subject completing the study
- •7. Use of an investigational device or investigational drug within 30 days or 5 half-lives (whichever is the longer) preceding the first dose of study medication
- •8. Patients considered unsuitable to participate by the research team (e.g., due to medical reasons, laboratory abnormalities, or subject?s unwillingness to comply with all study-related procedures)
- •9. Severe acute infection, or significant trauma (burns, fractures)
- •10. Pregnancy
- •11. Contraindications tocardiac magnetic resonance (CMR) scanning
- •11.1. Pacemakers, intracranial clips or other metal implants or foreign bodies
- •11.2. Claustrophobia
- •11.3. Renal Failure (eGFR<30mls/min)
- •12. History of alcohol or drug abuse within the past 6 months
- •13. History of congenital methaemoglobinaemia
- •14. Angiographically
- •14.1. Severe vessel tortuosity, diffuse disease or severe calcification is present which may impede successful delivery of the over the wire balloon
研究者
相似试验
已完成
不适用
SUBpectoral Local anaesthetic Infusion following MastEctomy - version 1 (SUBLIME)Breast CancerCancerISRCTN46621916Royal Cornwall Hospitals NHS Trust (UK)160
已完成
不适用
Theophylline With Inhaled CorticoSteroid (ICS)Topic: Primary Care Research Network for England, RespiratorySubtopic: Not Assigned, Respiratory (all Subtopics)Disease: Respiratory, All DiseasesRespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN27066620niversity of Aberdeen (UK)1,578
已完成
3 期
Safety and efficacy trial of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)Mental and Behavioural DisordersSchizophreniaISRCTN64695913Dainippon Sumitomo Pharma America Inc. (USA)480
已完成
不适用
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)ISRCTN80782810Cambridge University Hospitals NHS Foundation Trust and University of Cambridge748
已完成
不适用
PREoperative intraVENous iron To Treat anaemia in major surgery (PREVENTT)ISRCTN67322816niversity College London (UK)487
